Obstetrics and Gynecology

• 

  Publication Venue For

  • Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access..  141:419-420. 2023
  • TikTok, #IUD, and User Experience With Intrauterine Devices Reported on Social Media.  141:215-217. 2023
  • National Estimates of Labiaplasty Performance in the United States From 2016 to 2019..  140:271-274. 2022
  • Association of Body Mass Index With the Use of Health Care Resources in Low-Risk Nulliparous Pregnancies After 39 Weeks of Gestation..  139:866-876. 2022
  • Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.  135:1226-1226. 2020
  • In Reply..  135:1226-1227. 2020
  • Prevalence of a Good Perinatal Outcome With Cryopreserved Compared With Fresh Donor Oocytes..  135:709-716. 2020
  • Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis..  135:12-23. 2020
  • Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma: Correction.  133:830-830. 2019
  • Evaluation of a Quality Improvement Intervention That Eliminated Routine Use of Opioids After Cesarean Delivery..  133:91-97. 2019
  • ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza.  132:e169-e173. 2018
  • Survey of peripartum hysterectomy experiences: anticipated, unplanned, or averted..  123 Suppl 1:134S. 2014
  • Urachal Duct Carcinoma Complicating Pregnancy.  122:469-472. 2013
  • Vasa Previa.  122:352-357. 2013
  • In reply.  120:1209-1210. 2012
  • In reply.  120:1212-1213. 2012
  • Perioperative Evaluation in Herlyn-Werner-Wunderlich Syndrome.  120:948-951. 2012
  • Effect of vaginal lubricants on natural fertility..  120:44-51. 2012
  • Obstetrician-Gynecologists' Objections to and Willingness to Help Patients Obtain an Abortion (vol 118, pg 905, 2011).  118:1424-1424. 2011
  • Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years..  117:798-804. 2011
  • Association between first-trimester vaginal bleeding and miscarriage..  114:860-867. 2009
  • Defining success after surgery for pelvic organ prolapse..  114:600-609. 2009
  • Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology..  114:585-593. 2009
  • Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines..  114:674-678. 2009
  • Evaluation of two management strategies for preoperative grade 1 endometrial cancer..  114:7-15. 2009
  • In Reply.  114:168-169. 2009
  • Robotic gynecologic surgery..  114:168. 2009
  • Trauma in pregnancy..  114:147-160. 2009
  • Complication and Reoperation Rates After Apical Vaginal Prolapse Surgical Repair: A Systematic Review (vol 113, pg 367, 2009).  113:1377-1377. 2009
  • The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery..  113:1225-1229. 2009
  • Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study..  113:630-635. 2009
  • Progestin therapy of complex endometrial hyperplasia with and without atypia..  113:655-662. 2009
  • Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review..  113:367-373. 2009
  • Robotic gynecologic surgery..  112:1369-1384. 2008
  • Short-term outcomes of robotic sacrocolpopexy compared with abdominal sacrocolpopexy..  112:1201-1206. 2008
  • Medical and surgical treatment of placenta percreta to optimize bladder preservation..  112:421-424. 2008
  • The accuracy of predicting parity as a prerequisite for cesarean delivery on maternal request..  112:285-289. 2008
  • Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence..  112:49-55. 2008
  • Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial..  111:611-621. 2008
  • Air embolism during pregnancy..  111:481-482. 2008
  • Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry..  111:22-33. 2008
  • Hysterectomy rates in the United States, 2003..  110:1091-1095. 2007
  • Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy..  110:391-397. 2007
  • Preeclampsia risk in women exposed in utero to diethylstilbestrol..  110:113-120. 2007
  • The role of genetic testing for cancer susceptibility in gynecologic practice..  110:155-167. 2007
  • Anal sphincter laceration at vaginal delivery: is this event coded accurately?.  109:1141-1145. 2007
  • Clinical and pathologic correlates in surgical stage II endometrial carcinoma..  109:1062-1067. 2007
  • Successful Treatment of Dermatomyositis During Pregnancy With Intravenous Immunoglobulin Monotherapy.  109:561-563. 2007
  • Maternal serum cytokines in preterm premature rupture of membranes..  109:121-127. 2007
  • Cesarean delivery on maternal request: maternal and neonatal outcomes..  108:1517-1529. 2006
  • Endoanal ultrasound findings and fecal incontinence symptoms in women with and without recognized anal sphincter tears..  108:1394-1401. 2006
  • Fecal and urinary incontinence in primiparous women..  108:863-872. 2006
  • Reliability and agreement of urodynamics interpretations in a female pelvic medicine center..  108:315-323. 2006
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening..  107:997-1005. 2006
  • Baking soda pica: A case of hypokalemic metabolic alkalosis and rhabdomyolysis in pregnancy.  107:484-486. 2006
  • Baking soda pica: a case of hypokalemic metabolic alkalosis and rhabdomyolysis in pregnancy..  107:484-486. 2006
  • Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests..  107:321-328. 2006
  • Early risk factors for pregnancy loss in lupus..  107:293-299. 2006
  • Textbook recommendations for preventing and treating perineal injury at vaginal delivery..  107:361-366. 2006
  • Postpartum diabetes screening in women with a history of gestational diabetes..  106:1297-1303. 2005
  • Preventability of pregnancy-related deaths: results of a state-wide review..  106:1228-1234. 2005
  • The FIBROID Registry: symptom and quality-of-life status 1 year after therapy..  106:1309-1318. 2005
  • Adherent biofilms in bacterial vaginosis..  106:1013-1023. 2005
  • Pregnancy and changes in melanocytic nevi..  106:857-860. 2005
  • Incidence and risk factors for stroke in pregnancy and the puerperium..  106:509-516. 2005
  • Erratum: Regarding plan B: Science and politics cannot be separated (Obstetrics and Gynecology (2005) 105 (1149-1150)).  106:201. 2005
  • Prospective data collection of a new procedure by a specialty society: the FIBROID registry..  106:44-51. 2005
  • Regarding plan B: Science and politics cannot be separated (vol 105, pg 1149, 2005).  106:201-201. 2005
  • The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes..  106:52-59. 2005
  • Prior cesarean and the risk for placenta previa on second-trimester ultrasonography..  105:962-965. 2005
  • Regarding Plan B: science and politics cannot be separated..  105:1148-1150. 2005
  • von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system..  105:1223-1226. 2005
  • Antidepressant medication use [corrected] and risk of ovarian cancer..  105:725-730. 2005
  • Reduced fertilization rates in older men when cervical mucus is suboptimal..  105:788-793. 2005
  • Elective primary cesarean delivery: attitudes of urogynecology and maternal-fetal medicine specialists..  105:301-306. 2005
  • Flushing and papules in a middle-aged woman..  105:397-401. 2005
  • Adherent biofilms in bacterial vaginosis.  106:1013-1023. 2005
  • Antidepressant medication use for and risk of ovarian cancer (vol 105, pg 725, 2005).  105:1495-1495. 2005
  • Evaluation of Aa point and cotton-tipped swab test as predictors of urodynamic stress incontinence..  105:115-119. 2005
  • Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure..  105:167-173. 2005
  • Laparoscopic Burch colposuspension versus tension-free vaginal tape: a randomized trial..  104:1249-1258. 2004
  • Prenatal diagnosis of a trauma-related fetal epidural hematoma..  104:1298-1300. 2004
  • A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology..  104:770-776. 2004
  • Anal sphincter injury in women with pelvic floor disorders..  104:690-696. 2004
  • Testing for von Willebrand disease in women with menorrhagia: a systematic review..  104:381-388. 2004
  • Should older women have antepartum testing to prevent unexplained stillbirth?.  104:56-64. 2004
  • Transvaginal endoscopic removal of eroded mesh after abdominal sacral colpopexy..  103:1040-1042. 2004
  • Increased infertility with age in men and women..  103:51-56. 2004
  • Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects..  103:169-180. 2004
  • Suicide in pregnancy..  102:1306-1309. 2003
  • Patient rotation and resolution of unilateral cornual obstruction during hysterosalpingography..  102:1088. 2003
  • Predictors of clinical outcomes in the laparoscopic management of adnexal masses..  102:243-251. 2003
  • Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy..  102:196-197. 2003
  • Patient rotation and resolution of unilateral cornual obstruction during hysterosalpingography..  101:1275-1278. 2003
  • Vulvar mucus observations and the probability of pregnancy..  101:1285-1293. 2003
  • Effects of race and clinical factors on short-term outcomes of abdominal myomectomy..  101:881-884. 2003
  • Giant pelvic retroperitoneal leiomyoma arising from the rectal wall..  101:1132-1134. 2003
  • Embolic microspheres within ovarian arterial vasculature after uterine artery embolization..  100:883-886. 2002
  • Uterine artery embolization: what more do we need to know?.  100:847-848. 2002
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries..  100:740-748. 2002
  • Complications associated with optical-access laparoscopic trocars..  100:614. 2002
  • Management of uterine leiomyomata: what do we really know?.  100:8-17. 2002
  • Dementia presenting as postpartum depression..  99:925-928. 2002
  • Hyperemesis gravidarum complicated by Wernicke's encephalopathy..  99:875-877. 2002
  • Complications associated with optical-access laparoscopic trocars..  99:553-555. 2002
  • Indicators of cocaine exposure and preterm birth..  99:458-465. 2002
  • Sexual function in women with urinary incontinence and pelvic organ prolapse..  99:281-289. 2002
  • Embolic microspheres within ovarian arterial vasculature after uterine artery embolization.  100:883-886. 2002
  • Postmenopausal hormone use and skeletal fracture: Does the size of the benefit decrease with increasing age?.  100:364-368. 2002
  • Fulminant hepatic failure due to herpes simplex after hysteroscopy..  98:954-956. 2001
  • Obesity and preeclampsia: the potential role of inflammation..  98:757-762. 2001
  • Age at natural menopause and the risk of epithelial ovarian cancer..  98:85-90. 2001
  • Involving the male partner for interpreting the basal body temperature graph..  98:133-138. 2001
  • Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy..  97:808-809. 2001
  • Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy..  97:685-692. 2001
  • Favorable survival associated with microsatellite instability in endometrioid endometrial cancers..  97:417-422. 2001
  • Provider encouragement of breast-feeding: evidence from a national survey..  97:290-295. 2001
  • New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection..  97:70-76. 2001
  • Antepartum or postpartum isoniazid treatment of latent tuberculosis infection..  96:757-762. 2000
  • Knowledge about human papillomavirus among adolescents..  96:653-656. 2000
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening..  96:645-652. 2000
  • Laparoscopic secondary port conversion using a reusable blunt conical trocar..  96:634-635. 2000
  • Effect of patient position on clinical evaluation of pelvic organ prolapse..  96:18-22. 2000
  • A survey of pessary use by members of the American urogynecologic society..  95:931-935. 2000
  • Cigarette smoking and epithelial ovarian cancer by histologic type..  95:255-260. 2000
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery..  95:206-214. 2000
  • A survey of pessary use by members of the american urogynecologic society.  95:931-935. 2000
  • Prognostic factors in early-onset epithelial ovarian cancer: a population-based study..  95:119-127. 2000
  • Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women..  94:537-542. 1999
  • Hormonal treatment of an endometrial stromal nodule followed by local excision..  93:805-807. 1999
  • Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis..  93:880-888. 1999
  • Cystic fibrosis and the National Institutes of Health consensus statement: are obstetrician-gynecologists ready to comply?.  93:581-584. 1999
  • Criteria that indicate endometriosis is the cause of chronic pelvic pain..  93:473. 1999
  • Criteria that indicate endometriosis is the cause of chronic pelvic pain..  92:1029-1032. 1998
  • A comprehensive resident training program in operative endoscopy..  92:891. 1998
  • No-fault system of compensation for obstetric injury: winners and losers..  91:437-443. 1998
  • Size of the urogenital hiatus in the levator ani muscles in normal women and women with pelvic organ prolapse..  91:364-368. 1998
  • Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy..  91:174-181. 1998
  • A comprehensive resident training program in operative endoscopy [2] (multiple letters).  92:891. 1998
  • Risk of preeclampsia in second-trimester triploid pregnancies..  90:884-888. 1997
  • Cost-effectiveness of fetal lung maturity testing in preterm labor..  90:824-829. 1997
  • Sacral osteomyelitis: an unusual complication of abdominal sacral colpopexy..  90:689-691. 1997
  • Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use..  90:244-248. 1997
  • Evaluation of the postcoital test in cycles involving exogenous gonadotropins..  89:780-784. 1997
  • Hepatitis C in pregnancy..  89:883-890. 1997
  • Advanced maternal age and perinatal outcome: oocyte recipiency versus natural conception..  89:519-523. 1997
  • Post-term birth: risk factors and outcomes in a 10-year cohort of Norwegian births..  89:543-548. 1997
  • Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol..  89:340-345. 1997
  • Storage of newborn stem cells for future use..  89:300-303. 1997
  • Epithelial ovarian cancer risk among women with polycystic ovary syndrome..  88:554-559. 1996
  • Prenatal ultrasonographic findings associated with short bowel syndrome in two fetuses with gastroschisis..  88:676-678. 1996
  • Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?.  88:549-553. 1996
  • Perinatal management of a lingual teratoma..  87:848-851. 1996
  • Pharmacologic treatment of psychiatric disease in pregnancy and lactation: fetal and neonatal effects..  87:789-794. 1996
  • Pregnancy complications and birth outcomes in obese and normal-weight women: effects of gestational weight change..  87:389-394. 1996
  • An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene..  87:306-309. 1996
  • Postmenopausal bartholin gland enlargement: a hospital-based cancer risk assessment..  87:286-290. 1996
  • Learning from the community about barriers to health care [1].  87:797-798. 1996
  • Learning from the community about barriers to health care..  87:140-141. 1996
  • Postmenopausal bartholin gland enlargement a hospital-based cancer risk assessment.  87:286-290. 1996
  • Relationship between race and interval to treatment in endometrial cancer..  86:486-490. 1995
  • Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management..  86:318. 1995
  • Cesarean delivery: a reconsideration of terminology..  86:152-153. 1995
  • Mutational analysis of the estrogen-receptor gene in endometrial carcinoma..  86:33-37. 1995
  • Chemotherapy-induced apoptosis in epithelial ovarian cancers..  85:1007-1010. 1995
  • Porencephaly secondary to fetal trauma during amniocentesis..  85:865-867. 1995
  • Prenatal diagnosis and management of massive bilateral axillary cystic lymphangioma..  85:853-856. 1995
  • Reduction of pain and nausea after laparoscopic sterilization with bupivacaine, metoclopramide, scopolamine, ketorolac, and gastric suctioning..  85:687-691. 1995
  • Villoglandular adenocarcinoma of the cervix: a case report..  85:906-908. 1995
  • Magnetic resonance imaging of deep venous thrombosis in pregnant women with lower extremity edema..  85:603-607. 1995
  • Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management..  85:578-582. 1995
  • Decrease in myometrial beta-adrenergic receptors with prenatal cocaine use..  85:357-360. 1995
  • Follicle-stimulating hormone concentrations in relation to active and passive smoking..  85:407-411. 1995
  • Characterization of the effect of cocaine on catecholamine uptake by pregnant myometrium..  85:93-96. 1995
  • In reply:.  86:318. 1995
  • Relationship between race and interval to treatment in endometrial cancer.  86:486-490. 1995
  • Evaluation of prognostic factors and staging in gestational trophoblastic tumor..  84:969-973. 1994
  • Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia..  84:794-797. 1994
  • Management of chemotherapy in a pregnancy complicated by a large neuroblastoma..  84:665-668. 1994
  • Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium..  84:215-218. 1994
  • Prenatal ultrasound findings of linear nevus sebaceous and its association with cystic adenomatoid malformation of the lung..  83:860-862. 1994
  • Primary adenocarcinoma of the gallbladder presenting as primary gynecologic malignancy: a report of two cases..  83:831-834. 1994
  • Preoperative coagulation testing on a gynecologic oncology service..  83:438-444. 1994
  • The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer..  83:445-448. 1994
  • Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease..  83:113-117. 1994
  • Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas..  83:118-124. 1994
  • Laparoscopic injury of abdominal wall blood vessels: a report of three cases..  82:673-676. 1993
  • MUTATION AND OVEREXPRESSION OF P53 IN EARLY-STAGE EPITHELIAL OVARIAN-CANCER.  81:643-650. 1993
  • Mutation and overexpression of p53 in early-stage epithelial ovarian cancer..  81:643-650. 1993
  • hCG, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy..  81:705-709. 1993
  • Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.  81:643-650. 1993
  • Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma..  80:949-953. 1992
  • Radical hysterectomy in obese women..  80:940-943. 1992
  • The relationship of the umbilicus to the aortic bifurcation: implications for laparoscopic technique..  80:48-51. 1992
  • Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging..  79:993-997. 1992
  • Pregnancy complicated by Goodpasture syndrome..  79:806-808. 1992
  • Eubacterium nodatum mimics Actinomyces in intrauterine device-associated infections and other settings within the female genital tract..  79:534-538. 1992
  • Assessment of perineal floor function: electromyography with acrylic plug surface electrodes in nulliparous women..  78:1149-1151. 1991
  • Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women..  78:187-190. 1991
  • Cocaine blocks extraneuronal uptake of norepinephrine by the pregnant human uterus..  78:249-253. 1991
  • Preliminary experience with magnetic resonance imaging in patients with third-trimester bleeding.  78:424-429. 1991
  • RE: Clinical chorioamnionitis is not predicted by an ultrasonic biophysical profile in patients with premature rupture of membranes.  77:650-651. 1991
  • The clinical significance of blood transfusion at the time of radical hysterectomy..  77:165-166. 1991
  • Clinical chorioamnionitis is not predicted by an ultrasonic biophysical profile in patients with premature rupture of membranes..  76:1051-1054. 1990
  • A rapid method for detection of group B streptococcal colonization: testing at the bedside..  76:882-885. 1990
  • Fetal posterior urethral valve syndrome: a prospective application of antenatal prognostic criteria..  76:951-955. 1990
  • Computed tomography-guided fine-needle aspiration of retroperitoneal lymph nodes in gynecologic oncology..  76:612-616. 1990
  • Rapid assessment of fetal hemoglobin concentration with the HemoCue system..  76:723-724. 1990
  • EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND HER-2 NEU IN NORMAL AND NEOPLASTIC CERVIX, VULVA, AND VAGINA.  76:381-387. 1990
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina..  76:381-387. 1990
  • ORAL-CONTRACEPTIVES AND BREAST-CANCER - A CASE-CONTROL STUDY WITH HOSPITAL AND COMMUNITY CONTROLS.  76:395-402. 1990
  • Oral contraceptives and breast cancer: a case-control study with hospital and community controls..  76:395-402. 1990
  • A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy..  76:106-109. 1990
  • Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate..  76:118-123. 1990
  • Characteristics of uterine activity in gestations less than 20 weeks..  76:60S-62S. 1990
  • Management of preterm labor patients at home: does daily uterine activity monitoring and nursing support make a difference?.  76:32S-35S. 1990
  • Umbilical cord blood gas assessment of twins..  75:826-829. 1990
  • A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis..  75:684-689. 1990
  • The role of peptide growth factors in epithelial ovarian cancer..  75:255-262. 1990
  • Characteristics of uterine activity in gestations less than 20 weeks.  76:60S-62S. 1990
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.  76:381-387. 1990
  • Management of preterm labor patients at home: Does daily uterine activity monitoring and nursing support make a difference?.  76:32S-35S. 1990
  • Oral contraceptives and breast cancer: A case-control study with hospital and community controls.  76:395-402. 1990
  • Re: Oral contraceptives and breast cancer: A case-control study with hospital and community controls.  76:1147. 1990
  • Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery..  74:823-827. 1989
  • Direct fluorescent antibody testing for endocervical Chlamydia trachomatis: factors affecting accuracy..  72:803-809. 1988
  • Obstetric management of a fetus with nonlethal osteogenesis imperfecta..  72:477-479. 1988
  • The effect of cocaine abuse on birth weight and gestational age..  72:351-354. 1988
  • Changing rates of cesarean delivery: the Duke experience, 1978-1986..  72:98-101. 1988
  • Premature placental calcification in maternal cigarette smokers..  71:914-917. 1988
  • Treatment of uterine leiomyosarcoma..  71:845-850. 1988
  • Enterococci in post-cesarean endometritis..  71:159-162. 1988
  • Premature placental calcification in maternal cigarette smokers.  71:914-917. 1988
  • Treatment of uterine leiomyosarcoma.  71:845-850. 1988
  • Major morbidity after pelvic exenteration: a seven-year experience..  69:617-621. 1987
  • Ultrasonic recognition of the small-for-gestational-age fetus..  69:631-635. 1987
  • Who should have intravenous pyelograms before hysterectomy for benign disease?.  69:541-545. 1987
  • Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model..  69:146-150. 1987
  • Compartmental ovarian steroidogenesis in polycystic ovary syndrome..  68:638-644. 1986
  • Pregnancy-associated group B streptococcal endocarditis: a report of two fatal cases..  66:44S-47S. 1985
  • Pregnancy-associated group B streptococcal endocarditis: A report of two fatal cases.  66:44S-47S. 1985
  • Complications of low-dose heparin prophylaxis in gynecologic oncology surgery..  64:689-694. 1984
  • Gardnerella vaginalis bacteremia: a review of thirty cases..  64:170-172. 1984
  • Grieving characteristics after spontaneous abortion: a management approach..  64:119-122. 1984
  • Necrotizing fasciitis of vulvar origin in diabetic patients..  63:473-479. 1984
  • Selective management of abruptio placentae: a prospective study..  61:467-473. 1983
  • Pregnancy associated with paroxysmal nocturnal hemoglobinuria..  60:742-746. 1982
  • Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma..  60:546-551. 1982
  • Gynecologic manifestations of chronic graft-versus-host disease..  60:488-492. 1982
  • A trial of prophylactic cefamandole in extended gynecologic surgery..  59:309-314. 1982
  • A new abortion technique: intravaginal and intramuscular prostaglandin..  58:96-100. 1981
  • Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle..  58:26-30. 1981
  • Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections..  57:51-58. 1981
  • Turner phenotype in mother and daughter..  56:752-756. 1980
  • Urinary calculi in pregnancy..  56:462-466. 1980
  • Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone..  55:696-700. 1980
  • Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy..  54:269-277. 1979
  • Fetus papyraceus causing dystocia: inability to detect blighted twin antenatally..  54:381-383. 1979
  • Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization..  54:361-365. 1979
  • Dysgerminoma associated with pregnancy..  53:330-335. 1979
  • Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project..  53:309-317. 1979
  • Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project..  53:300-308. 1979
  • Pelvic mass presenting as meralgia paresthetica..  53:257-258. 1979
  • Comparison of histologic and colposcopic findings in DES-exposed females..  52:457-461. 1978
  • Prostaglandin F2alpha levels in human ovarian plasma in pregnancy and in a case of Halban's disease..  52:421-423. 1978
  • Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny..  52:129-137. 1978
  • The steroid profile of a virilizing ovarian tumor..  52:73-78. 1978
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol..  51:528-535. 1978
  • Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project..  51:453-458. 1978
  • Urogenital sinus origin of mucinous and ciliated cysts of the vulva..  51:347-351. 1978
  • Prostaglandin F 2 alpha production by the human ovary..  50:347-350. 1977
  • Evaluation of danazol as an oral contraceptive..  50:91-96. 1977
  • A computerized obstetric medical record..  49:502-509. 1977
  • Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure..  49:430-434. 1977
  • Primary trabecular carcinoid of the ovary..  49:202-207. 1977
  • Needle laparoscopy in patients with suspected bowel adhesions..  49:105-106. 1977
  • Cytology of 575 young women with prenatal exposure to diethylstilbestrol..  48:511-515. 1976
  • The effect of danazol in the treatment of chronic cystic mastitis..  48:93-98. 1976
  • Management of failed prostaglandin abortions..  47:473-478. 1976
  • Gonadotropin release in patients with androgen insensitivity. Testicular feminization syndrome..  47:331-336. 1976
  • Letter: Ultrasonic cephalometry..  47:382. 1976
  • Absence of bacteremia after insertion or removal of intrauterine devices..  47:207-209. 1976
  • Editorial: Problems in the examination of the DES-exposed female..  46:353-355. 1975
  • Factors affecting survival in stage I and stage II carcinoma of the cervix.  46:439-443. 1975
  • Problems in the examination of the des-exposed female.  46:353-355. 1975
  • Induction of labor with oral prostaglandin E2..  44:793-801. 1974
  • Renal scleroderma and pregnancy..  44:349-354. 1974
  • Toxemia..  41:475-476. 1973
  • Virilization during pregnancy associated with polycystic ovary disease..  40:156-162. 1972
  • Hydrops fetalis associated with idiopathic arterial calcification..  39:435-440. 1972
  • Hydrops fetalis associated with idiopathic arterial calcification.  39:434-441. 1972
  • Effect of an intrauterine contraceptive device on uterine motility in the rat..  27:238-242. 1966
  • Relaxant effect of diazepam on uterine muscle..  26:552-556. 1965
  • SPARTEINE AND OXYTOCIN: IN-VITRO COMPARISON ON PREGNANT-UTERUS MUSCLE..  23:2-8. 1964
  • PLASMA ANGIOTENSINASE ACTIVITY IN NORMAL AND TOXEMIC PREGNANCY..  22:316-323. 1963
  • Uterine relaxant properties of bradykinin in vitro..  22:102-107. 1963
  • Postpartum immunization. Report of a study..  20:774-780. 1962
  • Presentation to Publication: Analysis of Departmental Research Funding and Trainee Research Productivity 2022
  • Breast Symptoms After Pregnancy Loss and Abortion: An Observational Study 2020
  • Survey of Antepartum Women to Assess Barriers to Sequential Compression Device Compliance 2020
  • Parenthood and Medical Careers: The Challenges and Experiences of Physician Moms in the US 2019
  • Resident Education in Complex Obstetric Procedures: Are We Adequately Preparing Tomorrow's Obstetricians? 2019
  • A Descriptive Analysis of Abortion Clinics' Aftercare Instructions Following Surgical Abortion 2019
  • Debunking the Myth: Do MFM Fellows Negatively Impact Resident Obstetrical Skills [15H] 2019
  • Is Incision to Delivery Time Associated With Poor Neonatal Neurological Outcomes in Women With Class 3 Obesity? [31L] 2019
  • Management of Intraamniotic Infection After Spontaneous Vaginal Delivery: Is Nothing Really Enough? [24C] 2019
  • Maternal Weight Gain and Neonatal Outcomes in Women With Class III Obesity [29C] 2019
  • Maternal Weight Gain and Risk of Cesarean Delivery in Women With Class III Obesity [28N] 2019
  • Spiking in the Second Stage: The Significance of Isolated Maternal Fever During Labor [16A] 2019
  • Spiking in the Second Stage: What are the Neonatal Implications? 2019
  • Uterine Vascular Embolization Followed by Hysterectomy After Cesarean for MAP Without Extrauterine Involvement [32T] 2019
  • 5% Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized, Placebo-Controlled Trial 2019
  • Provider Comfort With Teaching Patients and Learns about Racial and Ethnic Disparities in Ob/Gyn Outcomes [8I] 2018
  • Subsequent Pregnancy Outcomes Following Use of an Intrauterine Tamponade Balloon for Postpartum Hemorrhage (PPH) [24C] 2017
  • Developing a Pilot Curriculum to Foster Humanism in Graduate Medical Education 2016
  • A Model to Predict Risk of Infection After Cesarean Delivery [16J] 2016
  • Alarming Rates of Antibiotic Resistance Among Organisms Causing Post-Cesarean Section Peritonitis in Rwanda [19J] 2016
  • Attitude Toward Research and Patient Provider Choice in the Academic Institution 2016
  • Failure to Receive Desired Postpartum Sterilization—One Year Contraceptive and Pregnancy Outcomes [15N] 2016
  • Patient's Perspective on Research 2016
  • Intern Boot Camp 2015
  • Micronized Progesterone Compared With Dydrogesterone for Threatened Miscarriage 2015
  • Belimumab Pregnancy Registry 2014
  • Assessing vaginal surgical skills using video motion analysis. 2009
  • First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation. 2008
  • Antenatal steroid use and predictors of preterm labor 2007
  • Adverse Pregnancy Outcomes Are Associated With Coronary Artery and Cardiovascular Disease Risk 2006
  • Adverse Pregnancy Outcomes Are Associated With Increased Risk for Mortality 2006
  • Psychosocial Impact of Chronic Vulvovaginal Disorders 2006
  • Early risk factors for pregnancy loss in lupus 2005
  • Permanent transcervical sterilization: The first 500 women treated in a multicenter trial 2005